PD61-01 CLINICAL OBSERVATION ON ROBOT-ASSISTED LAPAROSCOPIC RADIOFREQUENCY ABLATION FOR COMPLEX INTRARENAL TUMORSстатья из журнала
Аннотация: You have accessJournal of UrologyKidney Cancer: Localized: Ablative Therapy1 Apr 2018PD61-01 CLINICAL OBSERVATION ON ROBOT-ASSISTED LAPAROSCOPIC RADIOFREQUENCY ABLATION FOR COMPLEX INTRARENAL TUMORS Linfang Yao, Xiaozhi Zhao, Yang Yang, and Hongqian Guo Linfang YaoLinfang Yao More articles by this author , Xiaozhi ZhaoXiaozhi Zhao More articles by this author , Yang YangYang Yang More articles by this author , and Hongqian GuoHongqian Guo More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2825AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To evaluate the clinical safety, feasibility and efficacy of robot-assisted laparoscopic radiofrequency ablation(RLRFA) for complex intrarenal tumors with R.E.N.A.L. score=7. METHODS All patients receiving RLRFA during September 2016 and February 2017 were reviewed. Three cases of left renal tumors including one tumor in functional solitary kidney and 6 cases of right renal tumors including 3 tumors in anatomical solitary kidneys were diagnosed by B ultrasound and CT scanning. The maximum diameters of the tumors were 1.0~3.0cm. A1l patients were followed up with enhanced CT and contrast-enhanced ultrasonography. RESULTS The mean time of the operation was (113.1±61.8)min,and the mean blood loss was (23.3±17.3)m1. No patient accepted blood transfusion during and post operation. The postoperative hospital stay was 3-10 days. A1l the lesions were completely ablated on contrast-enhanced ultrasonography during operation and 1 week after operation. There was no statistic change of hemoglobin, serum creatinine,eGFR and creatinine clearance after operation(P>0.05). A1l of the 9 cases survived. No recurrence or metastasis was found during a mean follow-up period of 9(7-12) months. CONCLUSIONS RLRFA is safe and effective for complex intrarenal tumors with R.E.N.A.L. score=7 with the advantages of less complications, more nephron-sparing and fast recovery. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1152 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Linfang Yao More articles by this author Xiaozhi Zhao More articles by this author Yang Yang More articles by this author Hongqian Guo More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Год издания: 2018
Авторы: Linfang Yao, Xiaozhi Zhao, Yang Yang, Hongqian Guo
Издательство: Lippincott Williams & Wilkins
Источник: The Journal of Urology
Ключевые слова: Renal cell carcinoma treatment, Renal and related cancers, Pediatric Urology and Nephrology Studies
Открытый доступ: bronze
Том: 199
Выпуск: 4S